Structure Therapeutics Stock Forward View - Simple Regression
| GPCR Stock | 73.27 10.51 12.54% |
Structure Stock outlook is based on your current time horizon. Although Structure Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Structure Therapeutics' systematic risk associated with finding meaningful patterns of Structure Therapeutics fundamentals over time.
As of today the rsi of Structure Therapeutics' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.02) | EPS Estimate Current Year (1.37) | EPS Estimate Next Year (1.38) | Wall Street Target Price 107.8 | EPS Estimate Current Quarter (0.37) |
Using Structure Therapeutics hype-based prediction, you can estimate the value of Structure Therapeutics American from the perspective of Structure Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Structure Therapeutics using Structure Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Structure using crowd psychology based on the activity and movement of Structure Therapeutics' stock price.
Structure Therapeutics Short Interest
An investor who is long Structure Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Structure Therapeutics and may potentially protect profits, hedge Structure Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 33.881 | Short Percent 0.1179 | Short Ratio 5.08 | Shares Short Prior Month 6 M | 50 Day MA 64.8712 |
Structure Relative Strength Index
The Simple Regression forecasted value of Structure Therapeutics American on the next trading day is expected to be 94.88 with a mean absolute deviation of 6.87 and the sum of the absolute errors of 419.26.Structure Therapeutics Hype to Price Pattern
Investor biases related to Structure Therapeutics' public news can be used to forecast risks associated with an investment in Structure. The trend in average sentiment can be used to explain how an investor holding Structure can time the market purely based on public headlines and social activities around Structure Therapeutics American. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Structure Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Structure Therapeutics.
Structure Therapeutics Implied Volatility | 1.26 |
Structure Therapeutics' implied volatility exposes the market's sentiment of Structure Therapeutics American stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Structure Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Structure Therapeutics stock will not fluctuate a lot when Structure Therapeutics' options are near their expiration.
The Simple Regression forecasted value of Structure Therapeutics American on the next trading day is expected to be 94.88 with a mean absolute deviation of 6.87 and the sum of the absolute errors of 419.26. Structure Therapeutics after-hype prediction price | USD 88.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Structure | Build AI portfolio with Structure Stock |
Prediction based on Rule 16 of the current Structure contract
Based on the Rule 16, the options market is currently suggesting that Structure Therapeutics American will have an average daily up or down price movement of about 0.0788% per day over the life of the 2026-04-17 option contract. With Structure Therapeutics trading at USD 73.27, that is roughly USD 0.0577 . If you think that the market is fully incorporating Structure Therapeutics' daily price movement you should consider acquiring Structure Therapeutics American options at the current volatility level of 1.26%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Structure Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Structure Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Structure Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Structure Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Structure Therapeutics' open interest, investors have to compare it to Structure Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Structure Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Structure. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Structure Therapeutics Additional Predictive Modules
Most predictive techniques to examine Structure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Structure using various technical indicators. When you analyze Structure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Structure Therapeutics Simple Regression Price Forecast For the 6th of February
Given 90 days horizon, the Simple Regression forecasted value of Structure Therapeutics American on the next trading day is expected to be 94.88 with a mean absolute deviation of 6.87, mean absolute percentage error of 74.51, and the sum of the absolute errors of 419.26.Please note that although there have been many attempts to predict Structure Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Structure Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Structure Therapeutics Stock Forecast Pattern
| Backtest Structure Therapeutics | Structure Therapeutics Price Prediction | Research Analysis |
Structure Therapeutics Forecasted Value
In the context of forecasting Structure Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Structure Therapeutics' downside and upside margins for the forecasting period are 81.05 and 108.70, respectively. We have considered Structure Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Structure Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Structure Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 122.4215 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 6.8731 |
| MAPE | Mean absolute percentage error | 0.1297 |
| SAE | Sum of the absolute errors | 419.2605 |
Predictive Modules for Structure Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Structure Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Structure Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Structure Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Structure Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Structure Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Structure Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Structure Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Structure Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Structure Therapeutics' historical news coverage. Structure Therapeutics' after-hype downside and upside margins for the prediction period are 74.25 and 101.89, respectively. We have considered Structure Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Structure Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Structure Therapeutics is based on 3 months time horizon.
Structure Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Structure Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Structure Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Structure Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.18 | 13.82 | 4.29 | 0.32 | 12 Events / Month | 8 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
73.27 | 88.07 | 5.12 |
|
Structure Therapeutics Hype Timeline
Structure Therapeutics is currently traded for 73.27. The entity has historical hype elasticity of 4.29, and average elasticity to hype of competition of 0.32. Structure is forecasted to increase in value after the next headline, with the price projected to jump to 88.07 or above. The average volatility of media hype impact on the company the price is over 100%. The price gain on the next news is projected to be 5.12%, whereas the daily expected return is currently at 2.18%. The volatility of related hype on Structure Therapeutics is about 9337.84%, with the expected price after the next announcement by competition of 73.59. Structure Therapeutics generates negative cash flow from operationsGiven the investment horizon of 90 days the next forecasted press release will be in about 12 days. Check out Historical Fundamental Analysis of Structure Therapeutics to cross-verify your projections.Structure Therapeutics Related Hype Analysis
Having access to credible news sources related to Structure Therapeutics' direct competition is more important than ever and may enhance your ability to predict Structure Therapeutics' future price movements. Getting to know how Structure Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Structure Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EWTX | Edgewise Therapeutics | 0.71 | 10 per month | 4.15 | 0.12 | 12.91 | (5.57) | 38.85 | |
| VRDN | Viridian Therapeutics | (0.12) | 9 per month | 1.56 | 0.13 | 5.57 | (2.59) | 16.53 | |
| QURE | Uniqure NV | (1.97) | 10 per month | 0.00 | (0.13) | 9.37 | (10.75) | 49.34 | |
| OCUL | Ocular Therapeutix | (0.22) | 12 per month | 0.00 | (0.09) | 6.04 | (5.39) | 36.20 | |
| NUVB | Nuvation Bio | (0.36) | 8 per month | 4.61 | 0.05 | 7.33 | (5.78) | 68.61 | |
| GLPG | Galapagos NV ADR | 0.82 | 3 per month | 1.12 | 0.07 | 2.62 | (1.87) | 7.08 | |
| MESO | Mesoblast | 0.84 | 8 per month | 3.17 | 0.01 | 5.49 | (3.96) | 19.08 | |
| LQDA | Liquidia Technologies | 1.67 | 9 per month | 3.03 | 0.25 | 8.00 | (4.72) | 19.63 | |
| CLDX | Celldex Therapeutics | 0.10 | 9 per month | 0.00 | (0.04) | 6.44 | (5.57) | 13.96 | |
| ABCL | Abcellera Biologics | 0.01 | 9 per month | 0.00 | (0.16) | 5.90 | (8.62) | 22.32 |
Other Forecasting Options for Structure Therapeutics
For every potential investor in Structure, whether a beginner or expert, Structure Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Structure Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Structure. Basic forecasting techniques help filter out the noise by identifying Structure Therapeutics' price trends.Structure Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Structure Therapeutics stock to make a market-neutral strategy. Peer analysis of Structure Therapeutics could also be used in its relative valuation, which is a method of valuing Structure Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Structure Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Structure Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Structure Therapeutics shares will generate the highest return on investment. By undertsting and applying Structure Therapeutics stock market strength indicators, traders can identify Structure Therapeutics American entry and exit signals to maximize returns.
Structure Therapeutics Risk Indicators
The analysis of Structure Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Structure Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting structure stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.09 | |||
| Semi Deviation | 2.99 | |||
| Standard Deviation | 13.25 | |||
| Variance | 175.55 | |||
| Downside Variance | 14.58 | |||
| Semi Variance | 8.93 | |||
| Expected Short fall | (6.66) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Structure Therapeutics
The number of cover stories for Structure Therapeutics depends on current market conditions and Structure Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Structure Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Structure Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Structure Therapeutics Short Properties
Structure Therapeutics' future price predictability will typically decrease when Structure Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Structure Therapeutics American often depends not only on the future outlook of the potential Structure Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Structure Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 52.6 M | |
| Cash And Short Term Investments | 883.5 M |
Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.